Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	40.56B +125.1%
Revenue (ttm)	17.32B +4.1%
Net Income	706.00M
EPS	0.60
Shares Out	n/a
PE Ratio	57.46
Forward PE	12.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	28.40
Previous Close	33.00
Day's Range	28.40 - 28.40
52-Week Range	14.00 - 37.00
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About TEVJF

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 32,842
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 7, 2026

Data Sources Report a data error